ABT — Abbott Laboratories

Health Care · NYSE/Nasdaq. Last price 103.00 USD (-0.84% on the day). Raven's AI 12-month target: 108.00 USD. Updated 2026-11-20.

Paper-trade Abbott Laboratories free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 108.00 USD (+3.98% from 103.87 when it was set on 2026-11-20). Conviction: medium.

Catalysts: Diagnostic expansion; Dividend growth

Risks: Medical device deflation; Litigation costs

Earnings

Q3 2026 earnings per share: 1.42 USD against 1.42 expected (beat by 0.0%). EPS estimates for 2026: 5.52 USD (27 analysts), 2027: 5.94 USD (27 analysts). The 2026 estimate has moved -0.0% over 90 days.

Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks on NYSE/Nasdaq: ABBV AbbVie · AMGN Amgen · BMY Bristol-Myers Squibb · CVS CVS Health · DHR Danaher · GILD Gilead Sciences · ISRG Intuitive Surgical · JNJ Johnson & Johnson

RAVEN is taking longer than usual to load.
RELOAD